Clinical Social Workers in Kirtland Afb, NM Accepting Medicare

15 Clinical Social Workers found. Showing 1 - 15

Paige Loreen Andre-hudson Clinical Social Worker Medicare: Medicare Enrolled Practice Location: 2050a 2nd St Se, Kirtland Afb, NM 87117 Phone: 505-846-3200

Tina Yvette Bryant, LMSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 2050 A Second St, Se, Kirtland Afb, NM 87117 Phone: 505-846-3305    Fax: 505-846-3295

Mrs. Lesley Dale Pacheco, MSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 2050 A 2nd Street, Kirtland Afb, NM 87117 Phone: 505-846-0139    Fax: 505-846-6250

Lisa C Whitney, LISW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 377 Mdg/sgoh, 2050a Second Street Se, Kirtland Afb, NM 87117 Phone: 505-846-3305

Adrianna Miller Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 2050a 2nd St Se, Kirtland Afb, NM 87117 Phone: 505-846-3200

M. Melisse Barlow, MSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 2050a Second St. Se, Kirtland Afb, NM 87117 Phone: 505-853-4350

Kim M Romero, LISW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 2050a 2nd St Se, Kirtland Afb, NM 87117 Phone: 505-933-1482

Mr. Joseph Gerard Hogan, LISW Clinical Social Worker Medicare: Medicare Enrolled Practice Location: 2050a 2nd St Se, Kirtland Afb, NM 87117 Phone: 505-270-4387

Rachel Jane Darnell-miller, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 2050 A 2nd Street Se, Kirtland Afb, NM 87117 Phone: 505-846-3305

B Thomas Hail, LCSW Clinical Social Worker Medicare: Medicare Enrolled Practice Location: 2050a 2nd St Se, Kirtland Afb, NM 87117 Phone: 505-399-9115

James Palmer, LICSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 2050a 2nd St Se, Kirtland Afb, NM 87117 Phone: 505-846-3200

Mr. Jeremiah Goldberg, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 2050a 2nd St Se, Kirtland Afb, NM 87117 Phone: 505-846-3200

Judith Balderrama-lovato, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 2050a 2nd St Se, Kirtland Afb, NM 87117 Phone: 505-846-3322

Martha Vanessa Ragsdale, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 2050a 2nd St Se, Kirtland Afb, NM 87117 Phone: 505-846-3200

Ms. Tammy Denise Ali-carr, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 2050a 2nd St Se, Kirtland Afb, NM 87117 Phone: 901-517-5944

News Archive

Sectra OneScreen can effectively identify people at high risk for osteoporosis

A research team at the Karolinska Institute in Stockholm has conducted a study that shows how Sectra's online service, Sectra OneScreen, provides an efficient and inexpensive method for early identification of people in the "at-risk group" for osteoporosis. Sectra OneScreen can be combined with routine mammography examinations.

FDA approves Genzyme's Fabrazyme manufacturing plant in Framingham

Genzyme, a Sanofi company, announced today that the Food and Drug Administration (FDA) has approved its manufacturing plant in Framingham, Mass., for the production of Fabrazyme(agalsidase beta). This follows the previously announced approval by the European Medicines Agency (EMA) last week.

Westaim announces completion of second and final tranche of Subscription Receipts private placement

The Westaim Corporation announced that it has completed the second and final tranche of its private placement of subscription receipts (Subscription Receipts) with the sale today of 3,255,000 Subscription Receipts at a purchase price of $0.50 each for gross proceeds of $1,627,500 bringing the aggregate gross proceeds of the Subscription Receipt financing to $275,000,000. The terms of the Subscription Receipts and details regarding the initial tranche can be found in the Company's press release dated February 9, 2010.

CSI receives authorization to begin its pivotal trial of ORBIT II

Cardiovascular Systems, Inc. (CSI), has received Food and Drug Administration (FDA) conditional Investigational Device Exemption (IDE) approval to evaluate the safety and effectiveness of its Diamondback 360® System in the treatment of calcified coronary lesions. With this conditional approval, CSI is authorized to begin its pivotal trial, ORBIT II, in early 2010 and initially enroll up to 100 patients at as many as 50 U.S. sites.

Study highlights importance of five relationship maintenance strategies

What are you doing to keep your relationship alive? A University of Illinois study highlights the importance of five relationship maintenance strategies that couples can use to preserve or improve the quality of an intimate relationship.

Read more Medical News

› Verified 4 days ago